PM8002 for advanced solid tumors that have stopped responding
Treatments studied
Part of Cancer clinical trials.
This Phase 1/2 study tests PM8002 in people with advanced solid cancers to see if it can work and is safe. It may help if your cancer has measurable disease and you have not fully recovered from side effects of prior treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can freely choose to join, understand the study, sign consent, and complete required tests
- You are 18 to 75 years old and have a confirmed cancer diagnosis (from biopsy or fluid sample)
- You have at least one measurable tumor spot that has not been treated with local radiation or other local methods
- Your body systems are working well enough (kidney, liver, etc.), and you have an ECOG score of 0 or 1
- Your expected survival is at least 12 weeks, and side effects from prior cancer treatment have not fully gone away
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests PM54, a study drug, in people with advanced (cancer that has spread) solid tumors when standard treatments are no longer working. It focuses on safety and early signs of how well the treatment may work in specific cancer types.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This Phase 1/2 study tests two investigational medicines (PE0116 and PE0105) in people with advanced solid cancers that have spread or cannot be removed by surgery. It may help shrink tumors or slow disease when standard treatments have not worked or are not tolerated.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This Phase 1 study tests BAT8008 injection to see how safe it is, how well the body handles it, and how it affects the body’s drug levels. It’s for adults with advanced or metastatic solid tumors that are not responding to, or can’t be tolerated with, standard treatments.
This study tests an experimental drug called EP0089 for people with advanced solid tumors that haven't responded to other treatments. It aims to find a safe dose and see if it helps control the cancer.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.